Literature DB >> 15972409

Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging.

Eiji Tadamura1, Masaki Yamamuro, Shigeto Kubo, Shotaro Kanao, Tsuneo Saga, Masaki Harada, Muneo Ohba, Ryohei Hosokawa, Takeshi Kimura, Toru Kita, Kaori Togashi.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the usefulness of delayed enhanced MRI for detecting cardiac sarcoidosis and to clarify the relationship between the findings of MRI and those of radionuclide imaging.
CONCLUSION: Delayed enhanced MRI is considered a useful method for the early identification of cardiac sarcoidosis. Delayed hyperenhancement is frequently associated with a reduction of regional wall motion and thallium-201 perfusion defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972409     DOI: 10.2214/ajr.185.1.01850110

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  38 in total

Review 1.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

Review 2.  Delayed Myocardial Enhancement in Cardiac Magnetic Resonance Imaging.

Authors:  Arie Franco; Saeed Javidi; Stefan G Ruehm
Journal:  J Radiol Case Rep       Date:  2015-06-30

3.  Sarcoidosis presenting as complete heart block in a 45-year-old farmer: an aetiology not to miss.

Authors:  Tom Riddington; Thanh T Phan; Marissa Minns; Andrew Turley
Journal:  J R Soc Med       Date:  2013-10-09       Impact factor: 5.344

Review 4.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

Review 5.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

Review 6.  Cardiac magnetic resonance imaging in heart failure: where the alphabet begins!

Authors:  Ahmed Aljizeeri; Abdulbaset Sulaiman; Naji Alhulaimi; Ahmed Alsaileek; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

7.  Management of cardiac sarcoidosis in the United States: a Delphi study.

Authors:  Nabeel Y Hamzeh; Frederick S Wamboldt; Howard D Weinberger
Journal:  Chest       Date:  2011-07-07       Impact factor: 9.410

8.  Right ventricular sarcoidosis: is it time for updated diagnostic criteria?

Authors:  Kairav Vakil; Elina Minami; Daniel P Fishbein
Journal:  Tex Heart Inst J       Date:  2014-04-01

9.  Detection of myocardial damage in patients with sarcoidosis.

Authors:  Manesh R Patel; Peter J Cawley; John F Heitner; Igor Klem; Michele A Parker; Wael A Jaroudi; Trip J Meine; James B White; Michael D Elliott; Han W Kim; Robert M Judd; Raymond J Kim
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

Review 10.  Sarcoid heart disease.

Authors:  Simon W Dubrey; Alex Bell; Tarun K Mittal
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.